Drugs & Targets NCCN awarded $2M to study Taiho’s Trifluridine and Tipiracil in various cancers October 26, 2018Vol.44 No.40
Clinical Roundup Keytruda improved OS as monotherapy and in combination with chemo in first-line recurrent or metastatic head and neck cancer October 26, 2018Vol.44 No.40
Clinical Roundup Keytruda shows nearly 40% CR in high-risk non-muscle invasive bladder cancer unresponsive to standard of care October 26, 2018Vol.44 No.40
Clinical Roundup Loxo Oncology announces larotrectinib clinical update in patients with TRK Fusion cancers October 26, 2018Vol.44 No.40
Clinical Roundup Pfizer provides update on PALOMA-3 trial of IBRANCE in HR+, HER2- metastatic breast cancer October 26, 2018Vol.44 No.40
Clinical Roundup Data monitoring committee recommends continuation of SGX301 trial in cutaneous T-cell lymphoma October 26, 2018Vol.44 No.40
Clinical Roundup Data on Merck’s investigational STING agonist presented at ESMO 2018 October 26, 2018Vol.44 No.40
Clinical Roundup Zoledronic acid improves DFS in premenopausal HR+ early breast cancer October 26, 2018Vol.44 No.40
Clinical Roundup SOLO-1 phase III trial demonstrates Lynparza maintenance therapy cut the risk of disease progression or death by 70% in advanced BRCA-mutated ovarian cancer October 26, 2018Vol.44 No.40
Clinical Roundup Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer October 26, 2018Vol.44 No.40
